 Reports Net Revenues of 101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA ACCESSWIRE August 9, 2021 Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH Amphastar or the Company today reported results for the three months ended June 30, 2021. Second Quarter Highlights Net revenues of 101.7 million for the second quarter GAAP net income of 7.8 million, or 0.16 per share, for the second quarter Adjusted non-GAAP net income of 10.6 million, or 0.21 per share, for the second quarter Dr. Jack Zhang, Amphastars President and Chief Executive Officer, commented: Continued strong sales of glucagon, Primatene Mist and our epinephrine products led to another strong quarter of growth. 